Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Lifecore Biomedical, Inc. - Common Stock (NQ: LFCR ) 4.840 +0.090 (+1.89%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 10, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Lifecore Biomedical, Inc. - Common Stock < Previous 1 2 3 4 5 Next > Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings March 28, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire The Law Offices of Frank R. Cruz Announces Investigation of Lifecore Biomedical, Inc. (LFCR) on Behalf of Investors March 26, 2024 From Law Offices of Frank R. Cruz Via Business Wire Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update March 26, 2024 From Lifecore Biomedical, Inc. Via GlobeNewswire Preview: Lifecore Biomedical's Earnings August 30, 2023 Via Benzinga Recap: Lifecore Biomedical Q3 Earnings June 01, 2023 Via Benzinga Lifecore Class Action Lawsuit Investigation News – Potential to Make Claim, Recover Losses, Contact Johnson Fistel, LLP March 24, 2024 From Johnson Fistel, LLP Via Business Wire LIFECORE ALERT: Bragar Eagel & Squire, P.C. is Investigating Lifecore Biomedical, Inc. on Behalf of Lifecore Stockholders and Encourages Investors to Contact the Firm March 22, 2024 From Bragar Eagel & Squire Via GlobeNewswire Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Lifecore Biomedical, Inc. (LFCR) March 21, 2024 From Kirby McInerney LLP Via Business Wire Dow Surges 350 Points; Fed Holds Rates Steady March 20, 2024 U.S. stocks traded higher toward the end of trading, after the Federal Reserve left rates unchanged. The Dow traded up 0.91% to 39,467.76 while the NASDAQ rose 1.08% to 16,341.42. The S&P 500 also... Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session March 20, 2024 Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session March 20, 2024 Via Benzinga Crude Oil Surges 2%; Signet Jewelers Shares Spike Higher March 20, 2024 U.S. stocks traded mostly flat midway through trading, ahead of interest-rate decision from the Federal Reserve. The Dow traded up 0.03% to 39,123.89 while the NASDAQ fell 0.01% to 16,165.15. The S&P... Via Benzinga Topics Economy Stocks Exposures Fossil Fuels Interest Rates US Equities US Stocks Edge Lower Ahead Of Fed's Decision; General Mills Earnings Top Views March 20, 2024 U.S. stocks traded slightly lower this morning, ahead of interest-rate decision from the Federal Reserve. Following the market opening Wednesday, the Dow traded down 0.01% to 39,106.88 while the NASDAQ... Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities 12 Health Care Stocks Moving In Wednesday's Pre-Market Session March 20, 2024 Via Benzinga Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes March 20, 2024 From Lifecore Biomedical, Inc. Via GlobeNewswire Lifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023 March 20, 2024 Efforts now aligned toward the completion of its First Quarter Fiscal 2024 Report on Form 10-Q From Lifecore Biomedical, Inc. Via GlobeNewswire Lifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal February 16, 2024 Notice of Delisting Will Not Immediately Result in the Suspension or Delisting of the Company’s Securities From Lifecore Biomedical, Inc. Via GlobeNewswire Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report January 12, 2024 From Lifecore Biomedical, Inc. Via GlobeNewswire Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements January 05, 2024 From Lifecore Biomedical, Inc. Via GlobeNewswire Top 5 Risk Off Stocks That May Explode This Quarter December 13, 2023 The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies. Via Benzinga Lifecore Biomedical Provides Business Update December 13, 2023 From Lifecore Biomedical, Inc. Via GlobeNewswire Company Reaches Favorable Resolution Regarding Previously-Disclosed Investigation of Formerly-Held Subsidiary Yucatan Foods November 20, 2023 U.S. Department of Justice Declines Prosecution From Lifecore Biomedical, Inc. Via GlobeNewswire Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report October 18, 2023 From Lifecore Biomedical, Inc. Via GlobeNewswire Lifecore Biomedical Provides Update for Development Portfolio and Timing of Delayed Filings October 10, 2023 From Lifecore Biomedical, Inc. Via GlobeNewswire Lifecore Biomedical Reports Fourth Quarter and Full Fiscal Year 2023 Results August 31, 2023 From Lifecore Biomedical, Inc. Via GlobeNewswire Lifecore Biomedical Sets Fourth Quarter 2023 Earnings Conference Call for August 31, 2023 at 7:30 a.m. CT August 22, 2023 From Lifecore Biomedical, Inc. Via GlobeNewswire Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report August 22, 2023 From Lifecore Biomedical, Inc. Via GlobeNewswire Top 5 Risk Off Stocks That May Plunge In Q2 June 16, 2023 The most overbought stocks in the consumer staples sector presents an opportunity to go short on these overvalued companies. Via Benzinga Lifecore Biomedical Q3 Misses Street Estimates, Explores 'Strategic Alternatives' June 01, 2023 Lifecore Biomedical Inc (NASDAQ: LFCR) reported a Q3 FY23 revenue decline of 26% Y/Y to $27.60 million, Via Benzinga Earnings Scheduled For June 1, 2023 June 01, 2023 Companies Reporting Before The Bell • Hormel Foods (NYSE:HRL) is likely to report quarterly earnings at $0.40 per share on revenue of $3.05 billion. Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.